Medanta reported double-digit revenue growth in Q1FY25, but sluggish developing hospitals was a drag on the margins. The company can be a potential takeover target for major hospital operator.
What is covered in the Full Insight:
Company Background
Revenue Rise, Margins Remain Under Pressure in Q1FY25
Expansion Plans in Place, A Long Way Ahead
A Renewed Takeover Bid On The Cards?
Outlook and Valuation
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.